Market Overview

ACADIA Pharma Shares Move Higher as JMP Boosted Price Target from $16 to $27

Related ACAD
15 Stocks Moving In Friday's Pre-Market Session
Acadia Pharmaceuticals Pops And Drops
Acadia Is A Good Speculation - Cramer's Lightning Round (5/25/16) (Seeking Alpha)

JMP Securities maintains ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) with a Market Outperform and raises the price target from $16.00 to $27.00.

The stock has opened up more than 4 percent higher. With the stock last trading at $19.45, the firm's new price target implies potential upside of about 39 percent.

Latest Ratings for ACAD

May 2016Leerink SwannDowngradesOutperformMarket Perform
Feb 2016JP MorganMaintainsNeutral
Feb 2016Bank of AmericaInitiates Coverage onBuy

View More Analyst Ratings for ACAD
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings


Related Articles (ACAD)

View Comments and Join the Discussion!